Literature DB >> 23325218

Fanconi anaemia and the repair of Watson and Crick DNA crosslinks.

Molly C Kottemann1, Agata Smogorzewska.   

Abstract

The function of Fanconi anaemia proteins is to maintain genomic stability. Their main role is in the repair of DNA interstrand crosslinks, which, by covalently binding the Watson and the Crick strands of DNA, impede replication and transcription. Inappropriate repair of interstrand crosslinks causes genomic instability, leading to cancer; conversely, the toxicity of crosslinking agents makes them a powerful chemotherapeutic. Fanconi anaemia proteins can promote stem-cell function, prevent tumorigenesis, stabilize replication forks and inhibit inaccurate repair. Recent advances have identified endogenous aldehydes as possible culprits of DNA damage that may induce the phenotypes seen in patients with Fanconi anaemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23325218      PMCID: PMC3700363          DOI: 10.1038/nature11863

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  75 in total

1.  Mechanism of RAD51-dependent DNA interstrand cross-link repair.

Authors:  David T Long; Markus Räschle; Vladimir Joukov; Johannes C Walter
Journal:  Science       Date:  2011-07-01       Impact factor: 47.728

2.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.

Authors:  Philip S Rosenberg; Hannah Tamary; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

3.  Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice.

Authors:  Frédéric Langevin; Gerry P Crossan; Ivan V Rosado; Mark J Arends; Ketan J Patel
Journal:  Nature       Date:  2011-07-06       Impact factor: 49.962

4.  Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.

Authors:  Katharina Schlacher; Nicole Christ; Nicolas Siaud; Akinori Egashira; Hong Wu; Maria Jasin
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

Review 5.  DNA interstrand crosslink repair and cancer.

Authors:  Andrew J Deans; Stephen C West
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

6.  Functional and physical interaction between the mismatch repair and FA-BRCA pathways.

Authors:  Stacy A Williams; James B Wilson; Allison P Clark; Alyssa Mitson-Salazar; Andrei Tomashevski; Sahana Ananth; Peter M Glazer; O John Semmes; Allen E Bale; Nigel J Jones; Gary M Kupfer
Journal:  Hum Mol Genet       Date:  2011-08-24       Impact factor: 6.150

7.  Mutations in BRIP1 confer high risk of ovarian cancer.

Authors:  Thorunn Rafnar; Daniel F Gudbjartsson; Patrick Sulem; Aslaug Jonasdottir; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Soren Besenbacher; Pär Lundin; Simon N Stacey; Julius Gudmundsson; Olafur T Magnusson; Louise le Roux; Gudbjorg Orlygsdottir; Hafdis T Helgadottir; Hrefna Johannsdottir; Arnaldur Gylfason; Laufey Tryggvadottir; Jon G Jonasson; Ana de Juan; Eugenia Ortega; Jose M Ramon-Cajal; Maria D García-Prats; Carlos Mayordomo; Angeles Panadero; Fernando Rivera; Katja K H Aben; Anne M van Altena; Leon F A G Massuger; Mervi Aavikko; Paula M Kujala; Synnöve Staff; Lauri A Aaltonen; Kristrun Olafsdottir; Johannes Bjornsson; Augustine Kong; Anna Salvarsdottir; Hafsteinn Saemundsson; Karl Olafsson; Kristrun R Benediktsdottir; Jeffrey Gulcher; Gisli Masson; Lambertus A Kiemeney; Jose I Mayordomo; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2011-10-02       Impact factor: 38.330

8.  SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.

Authors:  Chantal Stoepker; Karolina Hain; Beatrice Schuster; Yvonne Hilhorst-Hofstee; Martin A Rooimans; Jurgen Steltenpool; Anneke B Oostra; Katharina Eirich; Elisabeth T Korthof; Aggie W M Nieuwint; Nicolaas G J Jaspers; Thomas Bettecken; Hans Joenje; Detlev Schindler; John Rouse; Johan P de Winter
Journal:  Nat Genet       Date:  2011-01-16       Impact factor: 38.330

9.  Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.

Authors:  Anderson T Wang; Blanka Sengerová; Emma Cattell; Takabumi Inagawa; Janet M Hartley; Konstantinos Kiakos; Nicola A Burgess-Brown; Lonnie P Swift; Jacqueline H Enzlin; Christopher J Schofield; Opher Gileadi; John A Hartley; Peter J McHugh
Journal:  Genes Dev       Date:  2011-09-01       Impact factor: 11.361

10.  Aberrant chromosome morphology in human cells defective for Holliday junction resolution.

Authors:  Thomas Wechsler; Scott Newman; Stephen C West
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

View more
  305 in total

1.  Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up.

Authors:  David I Kutler; Krupa R Patel; Arleen D Auerbach; Jennifer Kennedy; Francis P Lach; Erica Sanborn; Marc A Cohen; William I Kuhel; Agata Smogorzewska
Journal:  Laryngoscope       Date:  2015-10-20       Impact factor: 3.325

Review 2.  DNA replication stress: from molecular mechanisms to human disease.

Authors:  Sergio Muñoz; Juan Méndez
Journal:  Chromosoma       Date:  2016-01-21       Impact factor: 4.316

Review 3.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

Review 4.  Spectrin and its interacting partners in nuclear structure and function.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

5.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

6.  Replication-Dependent Unhooking of DNA Interstrand Cross-Links by the NEIL3 Glycosylase.

Authors:  Daniel R Semlow; Jieqiong Zhang; Magda Budzowska; Alexander C Drohat; Johannes C Walter
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

7.  HUS1 regulates in vivo responses to genotoxic chemotherapies.

Authors:  G Balmus; P X Lim; A Oswald; K R Hume; A Cassano; J Pierre; A Hill; W Huang; A August; T Stokol; T Southard; R S Weiss
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.

Authors:  Jianqiu Zou; Deli Zhang; Guang Qin; Xiangming Chen; Hongmin Wang; Dong Zhang
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.

Authors:  Naoya M Suzuki; Akira Niwa; Miharu Yabe; Asuka Hira; Chihiro Okada; Naoki Amano; Akira Watanabe; Ken-Ichiro Watanabe; Toshio Heike; Minoru Takata; Tatsutoshi Nakahata; Megumu K Saito
Journal:  Stem Cells Transl Med       Date:  2015-03-11       Impact factor: 6.940

10.  Suppression of non-homologous end joining does not rescue DNA repair defects in Fanconi anemia patient cells.

Authors:  Supawat Thongthip; Brooke A Conti; Francis P Lach; Agata Smogorzewska
Journal:  Cell Cycle       Date:  2020-08-30       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.